Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT06863363
PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults
A Multicenter, Randomized, Open-label, Parallel-controlled Clinical Trial Comparing the Efficacy and Safety of PEG-rhGH Injection Combined with Semaglutide Injection Versus Semaglutide Injection Monotherapy in Body Composition of Non-Diabetic Obese Adults
Sponsor: Shanghai Zhongshan Hospital
Conditions
Non-diabetic Obesity
Updated 1 time since 2025 Last updated: Mar 5, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06863363, this PHASE4 trial focuses on Non-diabetic Obesity and remains actively recruiting participants. Sponsored by Shanghai Zhongshan Hospital, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Shanghai Zhongshan Hospital
Data source: Shanghai Zhongshan Hospital
For direct contact, visit the study record on ClinicalTrials.gov .